• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRCC-TFE3双融合荧光原位杂交检测:一种在石蜡包埋组织中识别PRCC-TFE3肾细胞癌的新方法。

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.

作者信息

Xiong Lei, Chen Xiancheng, Liu Ning, Wang Zhen, Miao Baolei, Gan Weidong, Li Dongmei, Guo Hongqian

机构信息

Department of Urology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, China.

Department of Critical Care Medicine, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.

出版信息

PLoS One. 2017 Sep 26;12(9):e0185337. doi: 10.1371/journal.pone.0185337. eCollection 2017.

DOI:10.1371/journal.pone.0185337
PMID:28949976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5614571/
Abstract

PRCC-TFE3 renal cell carcinoma (RCC) is one of the most common types of Xp11.2 translocation renal cell carcinoma (tRCC), of which the diagnosis mainly relies on reverse transcription-polymerase chain reaction (RT-PCR) or chromosomal analysis in fresh frozen samples. Herein, we developed a new dual-fusion fluorescence in situ hybridization (FISH) probe to succinctly identify PRCC-TFE3 RCC in paraffin-embedded tissue. We immunohistochemically analyzed TFE3 and cathepsin K expression in 23 cases of Xp11.2 tRCC which had been confirmed by break-apart TFE3 FISH probe. Next, the dual-fusion FISH assay was performed on these selected cases. Twenty typical cases of clear renal cell carcinoma and 20 cases of papillary renal cell carcinoma were collected as control groups. Seven cases were finally confirmed as PRCC-TFE3 RCC by FISH detection, emerging dual-fusion signals, of which 2 cases were identified as PRCC-TFE3 RCC by RT-PCR previously. All remaining cases were negative for the PRCC-TFE3 rearrangement by FISH. The TFE3 immunohistochemistry was positive in 22/23 cases and the cathepsin K was positive in 16/23 cases. All 7 PRCC-TFE3 RCCs showed positive cathepsin K immunoreactivity. Our results reveal that PRCC-TFE3 dual-fusion FISH probe is an efficient and concise technique for diagnosing PRCC-TFE3 RCC in paraffin-embedded tissue.

摘要

PRCC-TFE3肾细胞癌(RCC)是Xp11.2易位性肾细胞癌(tRCC)最常见的类型之一,其诊断主要依赖于新鲜冰冻样本中的逆转录-聚合酶链反应(RT-PCR)或染色体分析。在此,我们开发了一种新的双融合荧光原位杂交(FISH)探针,以简洁地鉴定石蜡包埋组织中的PRCC-TFE3 RCC。我们对23例经TFE3断裂分离FISH探针证实的Xp11.2 tRCC病例进行了TFE3和组织蛋白酶K表达的免疫组化分析。接下来,对这些选定病例进行双融合FISH检测。收集20例典型的透明肾细胞癌病例和20例乳头状肾细胞癌病例作为对照组。最终通过FISH检测,7例出现双融合信号,被确诊为PRCC-TFE3 RCC,其中2例之前通过RT-PCR被鉴定为PRCC-TFE3 RCC。其余所有病例FISH检测PRCC-TFE3重排均为阴性。23例病例中,TFE3免疫组化22例阳性,组织蛋白酶K免疫组化16例阳性。所有7例PRCC-TFE3 RCC组织蛋白酶K免疫反应均呈阳性。我们的结果表明,PRCC-TFE3双融合FISH探针是诊断石蜡包埋组织中PRCC-TFE3 RCC的一种高效且简洁的技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/c2fe74a1c7a5/pone.0185337.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/c1cf5c657280/pone.0185337.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/df0b84794c2a/pone.0185337.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/c2fe74a1c7a5/pone.0185337.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/c1cf5c657280/pone.0185337.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/df0b84794c2a/pone.0185337.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65c5/5614571/c2fe74a1c7a5/pone.0185337.g003.jpg

相似文献

1
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.PRCC-TFE3双融合荧光原位杂交检测:一种在石蜡包埋组织中识别PRCC-TFE3肾细胞癌的新方法。
PLoS One. 2017 Sep 26;12(9):e0185337. doi: 10.1371/journal.pone.0185337. eCollection 2017.
2
Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.用于Xp11.2易位性肾细胞癌和肺泡软组织肉瘤的TFE3断裂分离荧光原位杂交检测法的验证与应用
Diagn Pathol. 2015 Sep 29;10:179. doi: 10.1186/s13000-015-0412-z.
3
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.TFE3 断裂分离 FISH 检测与 TFE3 或组织蛋白酶 K 免疫组化染色单独检测相比,对 Xp11.2 易位相关性肾细胞癌具有更高的敏感性:扩大形态学谱。
Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.
4
Combination of immunohistochemistry, FISH and RT-PCR shows high incidence of Xp11 translocation RCC: comparison of three different diagnostic methods.免疫组织化学、荧光原位杂交(FISH)和逆转录聚合酶链反应(RT-PCR)联合检测显示Xp11易位性肾细胞癌的高发病率:三种不同诊断方法的比较
Oncotarget. 2017 May 9;8(19):30756-30765. doi: 10.18632/oncotarget.16481.
5
Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.新设计的断裂分离和ASPL-TFE3双融合荧光原位杂交检测法在诊断Xp11.2易位性肾细胞癌和ASPL-TFE3肾细胞癌中具有应用价值:一篇遵循STARD规范的文章
Medicine (Baltimore). 2015 May;94(19):e873. doi: 10.1097/MD.0000000000000873.
6
Novel gene fusion of PRCC-MITF defines a new member of MiT family translocation renal cell carcinoma: clinicopathological analysis and detection of the gene fusion by RNA sequencing and FISH.新型 PRCC-MITF 基因融合定义了 MiT 家族易位性肾细胞癌的一个新成员:临床病理分析及通过 RNA 测序和 FISH 检测基因融合。
Histopathology. 2018 Apr;72(5):786-794. doi: 10.1111/his.13439. Epub 2018 Jan 10.
7
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.在肾脏肿瘤咨询服务中使用 TFE3 断裂 FISH 检测。
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
8
TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.TFE3融合变异分析确定了Xp11易位性癌症之间特定的临床病理关联。
Am J Surg Pathol. 2016 Jun;40(6):723-37. doi: 10.1097/PAS.0000000000000631.
9
Identification by FFPE RNA-Seq of a new recurrent inversion leading to RBM10-TFE3 fusion in renal cell carcinoma with subtle TFE3 break-apart FISH pattern.通过福尔马林固定石蜡包埋(FFPE)RNA测序鉴定出一种新的复发性倒位,该倒位在肾细胞癌中导致RBM10-TFE3融合,且具有微妙的TFE3断裂分离荧光原位杂交(FISH)模式。
Genes Chromosomes Cancer. 2016 Jun;55(6):541-8. doi: 10.1002/gcc.22356. Epub 2016 Apr 7.
10
SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.SFPQ/PSF-TFE3肾细胞癌:一项临床病理研究,着重于扩展的形态学,并回顾SFPQ-TFE3肾细胞癌与相应间叶性肿瘤之间的差异,尽管存在相同的基因融合。
Hum Pathol. 2017 May;63:190-200. doi: 10.1016/j.humpath.2017.02.022. Epub 2017 Mar 14.

引用本文的文献

1
MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report.儿童期伴腹膜后转移的MiT家族易位性肾细胞癌:一例报告
Front Pediatr. 2023 Jul 17;11:1141223. doi: 10.3389/fped.2023.1141223. eCollection 2023.
2
Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma.Xp11.2易位性肾细胞癌中四种常见融合亚型的临床和病理异质性
Front Oncol. 2023 Feb 3;13:1116648. doi: 10.3389/fonc.2023.1116648. eCollection 2023.
3
Xp11.2 Translocation Renal Cell Carcinoma With Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners.

本文引用的文献

1
RBM10-TFE3 Renal Cell Carcinoma: A Potential Diagnostic Pitfall Due to Cryptic Intrachromosomal Xp11.2 Inversion Resulting in False-negative TFE3 FISH.RBM10-TFE3肾细胞癌:由于隐匿性染色体Xp11.2倒位导致TFE3荧光原位杂交假阴性,可能成为诊断陷阱。
Am J Surg Pathol. 2017 May;41(5):655-662. doi: 10.1097/PAS.0000000000000835.
2
TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.TFE3融合变异分析确定了Xp11易位性癌症之间特定的临床病理关联。
Am J Surg Pathol. 2016 Jun;40(6):723-37. doi: 10.1097/PAS.0000000000000631.
3
Clinicopathological characteristics of Xp11.2 translocation renal cell carcinoma in adolescents and adults: Diagnosis using immunostaining of transcription factor E3 and fluorescence in situ hybridization analysis.
伴有重排的Xp11.2易位性肾细胞癌:不同融合伴侣的独特形态学特征及预后
Front Oncol. 2021 Nov 30;11:784993. doi: 10.3389/fonc.2021.784993. eCollection 2021.
4
NRF-1 directly regulates TFE3 and promotes the proliferation of renal cancer cells.NRF-1直接调控TFE3并促进肾癌细胞的增殖。
Oncol Lett. 2021 Sep;22(3):679. doi: 10.3892/ol.2021.12940. Epub 2021 Jul 22.
5
Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis.Xp11.2易位性肾细胞癌的分子异质性:荧光原位杂交中分裂信号模式与预后的相关性
Cancer Manag Res. 2021 Mar 15;13:2419-2431. doi: 10.2147/CMAR.S297457. eCollection 2021.
6
The suitability of NONO-TFE3 dual-fusion FISH assay as a diagnostic tool for NONO-TFE3 renal cell carcinoma.NONO-TFE3 双重融合 FISH 检测作为 NONO-TFE3 肾细胞癌诊断工具的适用性。
Sci Rep. 2020 Oct 1;10(1):16361. doi: 10.1038/s41598-020-73309-4.
7
Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.肝细胞癌分子遗传靶点及关键信号通路的生物信息学分析
Onco Targets Ther. 2019 Jul 2;12:5153-5162. doi: 10.2147/OTT.S198802. eCollection 2019.
8
Cell-Specific PEAR1 Methylation Studies Reveal a Locus that Coordinates Expression of Multiple Genes.细胞特异性 PEAR1 甲基化研究揭示了一个协调多个基因表达的基因座。
Int J Mol Sci. 2018 Apr 3;19(4):1069. doi: 10.3390/ijms19041069.
青少年及成人Xp11.2易位性肾细胞癌的临床病理特征:采用转录因子E3免疫染色及荧光原位杂交分析进行诊断
Int J Urol. 2016 Feb;23(2):140-5. doi: 10.1111/iju.13007. Epub 2015 Nov 13.
4
Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.新设计的断裂分离和ASPL-TFE3双融合荧光原位杂交检测法在诊断Xp11.2易位性肾细胞癌和ASPL-TFE3肾细胞癌中具有应用价值:一篇遵循STARD规范的文章
Medicine (Baltimore). 2015 May;94(19):e873. doi: 10.1097/MD.0000000000000873.
5
MiT family translocation renal cell carcinoma.MiT家族易位性肾细胞癌
Semin Diagn Pathol. 2015 Mar;32(2):103-13. doi: 10.1053/j.semdp.2015.02.003. Epub 2015 Feb 4.
6
Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.易位性肾细胞癌的下一代测序揭示了新的RNA剪接伙伴和染色质重塑基因的频繁突变。
Clin Cancer Res. 2014 Aug 1;20(15):4129-40. doi: 10.1158/1078-0432.CCR-13-3036. Epub 2014 Jun 4.
7
Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage.Xp11易位性肾细胞癌的临床异质性:融合亚型、年龄和分期的影响
Mod Pathol. 2014 Jun;27(6):875-86. doi: 10.1038/modpathol.2013.208. Epub 2013 Dec 6.
8
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.在肾脏肿瘤咨询服务中使用 TFE3 断裂 FISH 检测。
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
9
TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.TFE3 断裂分离 FISH 检测与 TFE3 或组织蛋白酶 K 免疫组化染色单独检测相比,对 Xp11.2 易位相关性肾细胞癌具有更高的敏感性:扩大形态学谱。
Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.
10
Diagnosis of Xp11 translocation renal cell carcinomas in adult patients under 50 years: interest and pitfalls of automated immunohistochemical detection of TFE3 protein.50 岁以下成年患者 Xp11 易位性肾细胞癌的诊断:TFE3 蛋白自动化免疫组织化学检测的意义和陷阱。
Pathol Res Pract. 2013 Feb 15;209(2):83-9. doi: 10.1016/j.prp.2012.10.013. Epub 2012 Dec 14.